CD44和RHAMM是具有双转移促进和抑制功能的微环境传感器
Cornelia Tolg1, Kathleen Allen Hill2, Eva Ann Turley1,3
1Cancer Research Laboratory Program, Lawson Health Research Institute, Victoria Hospital, London, ON, N6A 5W9, Canada.
了解CD44和RHAMM/HMMR等基因如何影响癌症转移是关键. 它们作为瘤促进剂或抑制剂的双重作用取决于背景,这使得针对癌症进展的向治疗复杂化.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 癌症转移是治疗中的一个主要挑战.
- 影响转移的特定基因是潜在的治疗点.
- 像CD44和RHAMM/HMMR这样的多功能蛋白在转移中表现出双重作用.
研究的目的:
- 审查CD44和RHAMM/HMMR转移抑制器与促进器功能的机制基础.
- 探索这些蛋白质功能的上下文性质.
- 为了指导精确的治疗向用于转移管理.
主要方法:
- 实验模型和机械学研究的文献综述.
- 对CD44和RHAMM/HMMR的双重功能进行分析.
- 探索微环境传感作用的探索.
主要成果:
- CD44和RHAMM/HMMR可以作为微环境传感器.
- 它们在促进或抑制转移方面的功能取决于环境.
- 了解机制对于治疗应用至关重要.
结论:
- 利用对多功能蛋白质的机理学知识可以改善向疗法.
- 精确的向对于有效的转移管理至关重要.
- 对CD44,RHAMM/HMMR和类似蛋白质的进一步研究是有必要的.
更多相关视频
09:42Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis
Published on: June 26, 2019
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
相关概念视频
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
